MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
about
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinomaMicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Essential role of miRNAs in orchestrating the biology of the tumor microenvironmentTargeting microRNAs as key modulators of tumor immune responseSignaling of miRNAs-FOXM1 in cancer and potential targeted therapyMicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancerThe role of miR-29b in cancer: regulation, function, and signalingMechanism of T cell regulation by microRNAsRadioimmunotherapy of human tumoursMicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabMicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia.MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancerWidespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.Comprehensive survey of human brain microRNA by deep sequencing.hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.The potential clinical applications and prospects of microRNAs in lung cancerDiagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphomaModeling microRNA-mRNA interactions using PLS regression in human colon cancer.Targeting microRNAs in cancer: rationale, strategies and challenges.Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.The inhibitory role of Mir-29 in growth of breast cancer cellsTumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanomaShielding the messenger (RNA): microRNA-based anticancer therapies.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancerNeuroblastoma: developmental biology, cancer genomics and immunotherapy.Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells.Immunotherapy targets in pediatric cancer.Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatmentB7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma.Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.Small molecules targeting microRNA for cancer therapy: Promises and obstacles.Epigenetic Therapy in Lung Cancer - Role of microRNAs.Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
P2860
Q21202158-0B3909A2-7B61-42B0-8147-7799B338C5B4Q21245700-FF64B9ED-8D56-4739-8424-90D3EE682A77Q26745667-D04EA535-34FC-455B-A81A-A1164CA82809Q26746972-5973F822-041E-4465-9856-6337FDBED579Q26825764-0243BBBF-D969-4469-A9B3-DAEA4463A6E3Q26849525-97A2F78B-E8C1-423B-96B9-D0388EC5D7E7Q26851543-C66A895E-387D-4312-9F0C-6E6732CC55FDQ27026265-6D1C7962-13B4-450F-A757-841CEACDF8C5Q28088825-5F50AFA0-22F4-4EF9-BCCB-D995D09AD951Q30415894-6611452E-0D75-45A9-A335-1F6B36977C30Q30982718-006F2912-CB30-49E7-A08C-FB58A4E839D2Q31037470-838D1BDE-9903-483C-B397-2B3C1D2FCDBEQ33516231-F61BFC5F-3572-45F5-8815-7D7C4380A69DQ33621924-D3E14913-16EB-4D61-B8CF-820DC8EFAB10Q33699231-72F4E041-EF87-444D-87DA-64B38C8E2BAAQ33721980-F1C2D34D-5FAE-4E81-88C6-ACB5FFDC7A32Q33734765-9064B8A9-AAA0-4E74-A2E9-6334FD874E42Q33737293-7A58FB62-5D43-4027-910B-3B1C961FF3B1Q33780259-7D3D2912-2BBD-4B43-A3DF-2BDAB39E8A5AQ33906108-62A119DD-4F16-443F-8C3D-565ECE2A2680Q34141089-B14C05B1-BCAC-4B21-AECC-AC506E67D919Q34191041-04FCFFD1-F28E-4934-B79B-ABDD08169967Q34249355-C86380B3-4F36-4C2A-8264-A51D5630B5FAQ34291894-313FDA09-A73D-4C84-A36D-2F68FD3B3796Q34577158-54319E17-A21B-464F-A71E-C7C5A31FA1C7Q34713622-91186B64-0BF0-49D1-B376-9B16A00D370CQ35070602-3DDA7A9B-7232-4F06-A89E-F8C967CC6DB4Q35104159-D6258E6B-4449-4735-8F8A-BB8EB73A5244Q35187280-1E93EFA2-80C9-4B1D-852F-378E8F29CAF4Q35283020-96FC6620-72D8-4F82-800B-18AE44E7E4CEQ35553322-763ECA8C-6634-46A9-8E89-8BD992F060C4Q35786347-34D2A9B5-CA8A-48EE-BD0E-6754E7A1FE87Q35867721-73A1C027-947D-411E-BD4E-553F240EDB0DQ35971029-BF967A8F-6B93-447A-A492-1A92B7C8F4CBQ36190723-62713E47-8182-4C43-9C24-8AEA4C2CF3B2Q36429035-7632A35A-5361-42A7-BBD6-42BBEF6C6A25Q36444198-69E32643-285C-4A50-BE9C-1C847CDFBADBQ36567511-7FCEE072-5BA5-4BC6-9843-8D3BD50ED0DEQ36938216-117536BD-07F9-409D-BFD9-DB5B09E7FA4DQ36998864-7F15A850-872F-4C68-9ABA-1CA535488500
P2860
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@en
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@nl
type
label
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@en
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@nl
prefLabel
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@en
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@nl
P2093
P2860
P1433
P1476
MicroRNA miR-29 modulates expr ...... therapy of human solid tumors.
@en
P2093
Hong-Fen Guo
Irene Y Cheung
Nai-Kong V Cheung
P2860
P304
P356
10.1158/0008-5472.CAN-08-4517
P407
P577
2009-07-07T00:00:00Z